Dear Reader,
We have identified several healthtech stocks which are expected to go “Ex-Dividend” starting today.
If you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
So please keep this in mind.
Below is our latest Dividend Report:
AmerisourceBergen
Symbol: ABC
Recent ABC Stock Price: $148.22
Average Analyst Price Target: $173.70 (17.19%)
ABC Market Cap: $30.49B
Expected Ex-Dividend Date for ABC stock: Aug 12 2022
Expected Payment Date for ABC stock: Aug 29 2022
Expected Dividend & Yield for ABC stock: 1.26%
Recent Analyst Action: Lisa Gill, analyst at J.P. Morgan, reiterates coverage on AmerisourceBergen (ABC) stock in the Healthcare sector with a Buy rating and a price target of $ 191 (1 week ago).
TipRanks.com also reports that AmerisourceBergen stock currently has 11 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $173.70 . The target pricing ranges from a high forecast of $191.00 down to a low forecast of $150.00. AmerisourceBergen (ABC)’s last closing stock price was $148.22 which would put the average price target at 17.19% upside.Here are 3rd party ratings for ABC stock:
- TipRanks.com: Moderate Buy
- TradingView.com: Strong Buy
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: Buy, Bottom 31% (175 out of 252)
--------------------------------------------------------------------------
Bio-Techne
Symbol: TECH
Recent TECH Stock Price: $374.43
Average Analyst Price Target: $494.43 (32.05%)
TECH Market Cap: $14.91B
Expected Ex-Dividend Date for TECH stock: Aug 12 2022
Expected Payment Date for TECH stock: Aug 29 2022
Expected Dividend & Yield for TECH stock: 0.35%
Recent Analyst Action: Jacob Johnson, analyst at Stephens, reiterates coverage on Bio-Techne (TECH) stock in the Healthcare sector with a Buy rating and a price target of $ 480 (1 week ago).
TipRanks.com also reports that Bio-Techne stock currently has 7 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $494.43 . The target pricing ranges from a high forecast of $580.00 down to a low forecast of $390.00. Bio-Techne (TECH)’s last closing stock price was $374.43 which would put the average price target at 32.05% upside.Here are 3rd party ratings for TECH stock:
- TipRanks.com: Strong Buy
- TradingView.com: Neutral
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: sell
- Zacks.com: Buy, Top 33% (82 out of 252)
--------------------------------------------------------------------------
Chemed
Symbol: CHE
Recent CHE Stock Price: $483.85
Average Analyst Price Target: n/a (11.81%)
CHE Market Cap: $7.25B
Expected Ex-Dividend Date for CHE stock: Aug 12 2022
Expected Payment Date for CHE stock: Sep 02 2022
Expected Dividend & Yield for CHE stock: 0.30%
Recent Analyst Action: Ben Hendrix, analyst at RBC Capital, reiterates coverage on Chemed (CHE) stock in the Healthcare sector with a Buy rating and a price target of $ 541 (1 week ago).
TipRanks.com also reports that Chemed stock currently has n/a analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is n/a . The target pricing ranges from a high forecast of n/a down to a low forecast of n/a. Chemed (CHE)’s last closing stock price was $483.85 which would put the average price target at 11.81% upside.Here are 3rd party ratings for CHE stock:
- TipRanks.com: Moderate Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: Weak sell
- Zacks.com: Hold, Bottom 39% (154 out of 252)
--------------------------------------------------------------------------
Eli Lilly & Co
Symbol: LLY
Recent LLY Stock Price: $301.17
Average Analyst Price Target: $354.90 (17.84%)
LLY Market Cap: $289.43B
Expected Ex-Dividend Date for LLY stock: Aug 12 2022
Expected Payment Date for LLY stock: Sep 09 2022
Expected Dividend & Yield for LLY stock: 1.21%
Recent Analyst Action: Robyn Karnauskas, analyst at Truist Financial, reiterates coverage on Eli Lilly & Co (LLY) stock in the Healthcare sector with a Buy rating and a price target of $ 348 (4 days ago).
TipRanks.com also reports that Eli Lilly & Co stock currently has 10 analysts offering 12-month price targets and the consensus is a Strong Buy rating with an average price target is $354.90 . The target pricing ranges from a high forecast of $395.00 down to a low forecast of $335.00. Eli Lilly & Co (LLY)’s last closing stock price was $301.17 which would put the average price target at 17.84% upside.Here are 3rd party ratings for LLY stock:
- TipRanks.com: Strong Buy
- TradingView.com: Sell
- Yahoo! Finance: Bullish Short-Term Outlook
- Barchart.com: buy
- Zacks.com: Hold, Top 35% (87 out of 252)
--------------------------------------------------------------------------
Novo Nordisk
Symbol: NVO
Recent NVO Stock Price: $108.79
Average Analyst Price Target: $133.00 (22.25%)
NVO Market Cap: $243.36B
Expected Ex-Dividend Date for NVO stock: Aug 12 2022
Expected Payment Date for NVO stock: Aug 23 2022
Expected Dividend & Yield for NVO stock: 1.08%
Recent Analyst Action: Michael Leuchten, analyst at UBS, reiterates coverage on Novo Nordisk (NVO) stock in the Healthcare sector with a Sell rating and a price target of n/a (1 month ago).
TipRanks.com also reports that Novo Nordisk stock currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $133.00 . The target pricing ranges from a high forecast of $133.00 down to a low forecast of $133.00. Novo Nordisk (NVO)’s last closing stock price was $108.79 which would put the average price target at 22.25% upside.Here are 3rd party ratings for NVO stock:
- TipRanks.com: Moderate Buy
- TradingView.com: Neutral
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Weak buy
- Zacks.com: Hold, Top 35% (87 out of 252)
--------------------------------------------------------------------------
Organon
Symbol: OGN
Recent OGN Stock Price: $31.69
Average Analyst Price Target: $37.33 (17.80%)
OGN Market Cap: $7.99B
Expected Ex-Dividend Date for OGN stock: Aug 12 2022
Expected Payment Date for OGN stock: Sep 15 2022
Expected Dividend & Yield for OGN stock: 3.57%
Recent Analyst Action: Jason Gerberry, analyst at Bank of America Securities, reiterates coverage on Organon (OGN) stock in the Healthcare sector with a Hold rating and a price target of $ 37 (1 week ago).
TipRanks.com also reports that Organon stock currently has 3 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $37.33 . The target pricing ranges from a high forecast of $41.00 down to a low forecast of $34.00. Organon (OGN)’s last closing stock price was $31.69 which would put the average price target at 17.80% upside.Here are 3rd party ratings for OGN stock:
- TipRanks.com: Moderate Buy
- TradingView.com: Sell
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Hold, Top 38% (95 out of 252)
--------------------------------------------------------------------------
Teleflex
Symbol: TFX
Recent TFX Stock Price: $253.87
Average Analyst Price Target: $293.00 (15.41%)
TFX Market Cap: $11.92B
Expected Ex-Dividend Date for TFX stock: Aug 12 2022
Expected Payment Date for TFX stock: Sep 15 2022
Expected Dividend & Yield for TFX stock: 0.55%
Recent Analyst Action: Jayson Bedford, analyst at Raymond James, reiterates coverage on Teleflex (TFX) stock in the Healthcare sector with a Buy rating and a price target of $ 266 (1 week ago).
TipRanks.com also reports that Teleflex stock currently has 10 analysts offering 12-month price targets and the consensus is a Moderate Buy rating with an average price target is $293.00 . The target pricing ranges from a high forecast of $370.00 down to a low forecast of $248.00. Teleflex (TFX)’s last closing stock price was $253.87 which would put the average price target at 15.41% upside.Here are 3rd party ratings for TFX stock:
- TipRanks.com: Moderate Buy
- TradingView.com: Buy
- Yahoo! Finance: Bearish Short-Term Outlook
- Barchart.com: Strong sell
- Zacks.com: Sell, Bottom 47% (133 out of 252)
--------------------------------------------------------------------------
And there you have it...
Keep in mind, if you purchase a stock on its ex-dividend date or after, you will not receive the next dividend payment.
Instead, the seller gets the dividend. If you purchase before the ex-dividend date, you get the dividend.
If you sell your stock before the ex-dividend date, you also are selling away your right to the stock dividend.
If you have questions about specific dividends, you should consult with your financial advisor or visit Investor.gov for more information.
Sincerely,
The Editor, HealthTechMovers.com
HealthTechMovers.com (HTM) is built for investors who are interested in healthcare stocks, health insurance stocks, healthcare technology stocks, biotechnology stocks, pharmaceutical stocks, healthcare service provider stocks, life science stocks and more. HTM aggregates market data from top tier financial content providers like Barchart.com, Tipranks.com, TradingView.com, Yahoo! Finance, and Zacks.com. The research and editorial team behind HTM consolidates this aggregated data into easily consumable reports used to produce articles, newsletters, and web content. The reports produced by HTM contain timely information stock analysis, stock price targets, earnings announcements, insider trades, dividends, and top moving stocks.
